Jie-Ru Yang, Jie-Ru Yang, Yu-Xin Tian, Yu-Xin Tian, Jin-E. Li, Jin-E. Li, . . . Kai Wang. (2024). Mex3a promoter hypomethylation can be utilized to diagnose HBV-associated hepatocellular carcinoma: A randomized controlled trial. Frontiers Media S.A..
Chicago Style (17th ed.) CitationJie-Ru Yang, et al. Mex3a Promoter Hypomethylation Can Be Utilized to Diagnose HBV-associated Hepatocellular Carcinoma: A Randomized Controlled Trial. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationJie-Ru Yang, et al. Mex3a Promoter Hypomethylation Can Be Utilized to Diagnose HBV-associated Hepatocellular Carcinoma: A Randomized Controlled Trial. Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.